Search
Oncology Institute Inc
TOIAdd to Watchlist
5.130USD
0.0000.00%
Close 08-03 16:00（ET）
652.26MMarket Cap
LossP/E TTM
About Oncology Institute Inc Company
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Oncology Institute Inc Profile
Ticker SymbolTOI
Company nameOncology Institute Inc
IPO dateMar 13, 2020
CEOVirnich (Daniel)
Number of employees825
Security typeOrdinary Share
Fiscal year-endMar 13
Address18000 Studebaker Rd
CityCERRITOS
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code90703
Phone15627353226
Websitehttps://theoncologyinstitute.com/
Ticker SymbolTOI
IPO dateMar 13, 2020
CEOVirnich (Daniel)
Company Executives of Oncology Institute Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
150.05K
+22.08%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
150.05K
+22.08%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
150.05K
+22.08%
Mr. Mark D. Stolper
Mr. Mark D. Stolper
Independent Director
Independent Director
56.96K
--
Mr. Mark D. Stolper
Mr. Mark D. Stolper
Independent Director
Independent Director
56.96K
--
Mr. Mark D. Stolper
Mr. Mark D. Stolper
Independent Director
Independent Director
56.96K
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
150.05K
+22.08%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
150.05K
+22.08%
FAQs
Who are the top five shareholders of Oncology Institute Inc?
The top five shareholders of Oncology Institute Inc are: Dr. Daniel Virnich, M.D.
How many institutions hold shares of Oncology Institute Inc (TOI)?
As of 2026Q1, 204 institutions hold shares of Oncology Institute Inc, with a combined market value of approximately 47.47M, accounting for 47.57% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -10136464.00.
What is the biggest source of revenue for Oncology Institute Inc?
In 2026Q1, the Dispensary revenue business generated the highest revenue for Oncology Institute Inc, amounting to 269.18M and accounting for 53.54% of total revenue.